Association between depressive symptoms and use of HMG-CoA reductase inhibitors (statins), corticosteroids and histamine H(2) receptor antagonists in community-dwelling older persons: cross-sectional analysis of a population-based cohort.

Drugs & Aging
Liang FengTze-Pin Ng

Abstract

Strong evidence supporting the existence of causal associations of drug use with depression is often lacking from empirical studies. Limited evidence suggests an inverse association of use of HMG-CoA reductase inhibitors (statins) with depressive symptoms. Sparse and sometimes conflicting data in this respect have also been reported for corticosteroids, histamine H(2) receptor antagonists and antihypertensive agents. To identify associations between use of different drug classes and depressive symptoms in community-dwelling older patients and to determine whether any such associations varied between young-old and old-old patients. We analysed cross-sectional data from a population-based cohort of 2804 older adults aged > or =55 years, in whom specific drug use was systematically identified from self-reports and physical inspection of medication labels. Depressive symptoms were determined using the 15-item Geriatric Depression Scale (GDS), with a GDS score > or =5 defining the presence of depressive symptoms. Multivariate analysis controlling for the confounding effects of risk factors and correlates of depression revealed significant associations between depressive symptoms and use of statins (odds ratio [OR] 0.71; 95% CI 0.52,...Continue Reading

References

Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Mar 21, 1992·Lancet·H Engelberg
Aug 11, 1990·BMJ : British Medical Journal·M F MuldoonK A Matthews
Jan 1, 1984·European Journal of Clinical Pharmacology·A N Nicholson, B M Stone
Jun 1, 1981·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·R F BillingsV M Rakoff
Aug 13, 1994·BMJ : British Medical Journal·E VartiainenC Ehnholm
May 21, 1994·BMJ : British Medical Journal·S L BrownF J Kohout
Jan 9, 1993·Lancet·R E MorganD L Wingard
Jan 1, 1996·International Journal of Psychiatry in Medicine·S B PattenE J Love
Oct 1, 1996·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·S B PattenE J Love
Apr 1, 1997·Journal of Clinical Gastroenterology·S LevensteinM W Smith
Mar 14, 1998·Annals of Internal Medicine·B A Golomb
Dec 9, 1998·International Journal of Psychiatry in Medicine·T A MurbergS Svebak
Jan 5, 2000·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·E S BrownV A Nejtek
May 12, 2000·The American Journal of Medicine·M F MuldoonS B Manuck
Sep 14, 2000·International Journal of Geriatric Psychiatry·P P LimS Sahadevan
Jan 5, 2001·BMJ : British Medical Journal·M F MuldoonS H Belle
Oct 11, 2002·Suicide & Life-threatening Behavior·David Lester
Sep 10, 2003·Archives of Internal Medicine·Chen-Chang YangHershel Jick
Dec 4, 2003·Drugs & Aging·Lynne M Bang, Karen L Goa
Jun 9, 2004·Psychotherapy and Psychosomatics·Scott B Patten, Corrado Barbui
Jan 20, 2006·Journal of the American Geriatrics Society·Tze-Pin NgEe-Heok Kua
Feb 3, 2007·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Tze-Pin NgEe-Heok Kua
Apr 5, 2007·International Journal of Geriatric Psychiatry·Matthew NitiChay Hoon Tan
Nov 13, 2007·Journal of Affective Disorders·B F P BroekmanT P Ng

❮ Previous
Next ❯

Citations

Jun 19, 2013·Expert Opinion on Pharmacotherapy·Hong YouJinnan Zhang
Nov 13, 2014·International Journal of Molecular Sciences·Amelia J McFarlandAndrew K Davey
Dec 5, 2014·BMC Psychiatry·Cassie RedlichXinjun Li
Oct 3, 2015·Journal of Cross-cultural Gerontology·Jinhui LiSchubert Foo
Jun 25, 2010·Pharmacoepidemiology and Drug Safety·Liang FengTze Pin Ng
Apr 30, 2013·Pharmacotherapy·Ishak MansiEric M Mortensen
Aug 3, 2010·International Journal of Geriatric Psychiatry·Angelique ChanTruls Ostbye
Mar 3, 2015·Neurología : publicación oficial de la Sociedad Española de Neurología·A Robles Bayón, F Gude Sampedro
Dec 7, 2013·Journal of Clinical Psychopharmacology·Jae-Min KimJin-Sang Yoon
Jan 10, 2021·Journal of Affective Disorders·Ming-Chia LeeJeng-Chuan Shiang
Aug 14, 2021·Frontiers in Psychiatry·Riccardo De GiorgiCatherine J Harmer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.